(Q40862084)
Statements
Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects (English)
Perricaudet M
1 reference
Fernandez N
Duffour MT
Tursz T
Zitvogel L